How to Deal with GLP-1 Induced Muscle Loss

The use of GLP-1 receptor agonists like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) has revolutionized obesity treatment, but a significant clinical challenge has emerged: GLP-1 induced muscle loss.   While these medications are highly effective for weight reduction, research indicates that approximately 25% to 45% of the weight lost can come from lean body mass (LBM),